Pandemic treatments on trial: the bigger picture. N of many thinking in an N of one scenario

Tom Kotsimbos, Marc Humbert

Source: Eur Respir J, 56 (3) 2002281; 10.1183/13993003.02281-2020
Journal Issue: September
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Tom Kotsimbos, Marc Humbert. Pandemic treatments on trial: the bigger picture. N of many thinking in an N of one scenario. Eur Respir J, 56 (3) 2002281; 10.1183/13993003.02281-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A trial like ALIC4E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?
Source: ERJ Open Res, 4 (2) 00046-2018; 10.1183/23120541.00046-2018
Year: 2018



Pandemic scenario 1: outbreak investigation
Source: ERS Course 2017 - Acute respiratory pandemics: how to plan for and manage
Year: 2017

Large trials, new knowledge: the changing face of COPD management
Source: Eur Respir J 2015; 45: 1692-1703
Year: 2015




Late Breaking Abstract - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof of concept clinical trial
Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment
Year: 2021



Adapting asthma clinical trials in response to the COVID-19 pandemic - the BenRex study design
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Treatment of COPD and the TOnado trial: a tempest in a teapot?
Source: Eur Respir J 2015; 45: 869-871
Year: 2015


Clinical trials during the COVID-19 pandemic: research design and lessons
Source: Eur Respir Monogr 2021; 94: 214-231
Year: 2021


Data partitioning from the two waves of COVID-19 pandemic: is the landscape really evolving? A single institution experience.
Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19
Year: 2021


Management of COPD in Australian general practices: experiences from a cluster randomised trial
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017

The way forward: how to link real-life situations and clinical trial results
Source: Annual Congress 2013 - Lunchtime Session "Tiotropium soft mist inhaler and mortality in COPD: results of the TIOSPIR clinical trial"
Year: 2013

COVID-19: Vaccines – what are they and how do they work (current and trials)
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021

New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
Source: Eur Respir Rev 2014; 23: 367-378
Year: 2014



Understanding the analysis of the Canadian lung volume reduction surgery (CLVR) trial: future applications
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008


Treatment for NTM: when, how... and what next?
Source: ERS Course 2015
Year: 2015